Impulse Qingdao Health Tech Co. Ltd. Class A

Impulse Qingdao Health Tech Co. Ltd. Class A

SSZSE:002899
19.67
CNY
+0.27
(+1.39%)
0.37EPS
58.87P/E
3.22BMarket Cap
Oct 30Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
6.64
5.75
8.16
8.68
8.76
7.53
7.79
7.24
7.44
6.91
7.41
8.79
8.03
8.38
Basic EPS, GAAP
0.68
0.62
0.85
0.95
0.85
0.52
0.42
0.33
0.15
0.55
0.73
0.79
0.43
0.37
Free Cash Flow per Basic Share
- -
0.54
1.13
0.77
0.15
-0.38
0.14
0.61
-3.19
-2.94
-0.4
0.24
0.4
- -
Dividend per Share
0.12
0.44
0.18
0.17
0.09
0.08
0.1
- -
0.11
0.21
0.31
0.29
0.2
0.28
Book Value per Share
2.01
2.77
4.02
4.82
7.93
8.38
8.71
9.04
9.14
9.67
10.34
11.51
11.87
11.74
Tangible Book Value per Share
1.88
2.47
3.72
4.53
7.61
7.6
7.93
8.27
8.41
8.97
9.63
10.93
11.29
11.18
Basic Weighted Avg Shares
90
120
90
90
98
121
120
120
116
119
121
138
146
144
Sales/Revenue/Turnover
597
690
731
779
857
908
938
868
864
825
895
1,214
1,176
1,203
Operating Margin (%)
15.37
14.88
12.39
12.85
12.48
7.11
5.49
7.11
6.63
7.61
12.01
13.04
7.13
7.3
Depreciation Expense
- -
12
14
16
17
18
20
20
23
22
19
57
85
- -
Net Income, GAAP
61
74
76
85
83
63
51
40
17
66
88
109
63
53
Effective Tax Rate (%)
15.78
14.86
13.7
15.99
12.42
12.35
9.14
2.83
0.34
- -
12.89
10.65
11.71
12.81
Profit Margin (%)
10.19
10.76
10.42
10.94
9.7
6.91
5.39
4.56
2.02
7.96
9.85
8.99
5.36
4.42
Working Capital
10
48
151
194
683
684
757
765
815
559
452
687
653
629
LT Debt
- -
- -
29
- -
- -
- -
- -
9
408
536
627
590
477
524
Total Equity
181
250
361
434
951
1,006
1,045
1,084
1,097
1,160
1,241
1,702
1,754
1,736
Return on Invested Capital (%)
- -
18
17.59
18.32
11.31
5.86
4.81
3.85
3.1
- -
4.93
5.29
2.85
2.31
Return on Capital (%)
- -
21.58
19.57
19.69
11.66
6.33
4.95
3.68
1.36
- -
4.78
5.99
3.31
2.78
Return on Common Equity (%)
- -
34.5
24.93
21.42
12.01
6.41
4.93
3.72
1.6
5.82
7.34
7.42
3.65
3.08

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
156
187
118
LT Borrowings
473
448
516
LT Finance Leases
4
12
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
148
148
148
Market Capitalization
4,045
4,196
3,222

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,232
1,268
1,181
Cash, Cash Equivalents & STI
690
668
571
Accounts Receivable, Net
199
279
285
Inventories
222
223
231
Total Current Liabilities
579
603
552
Payables & Accruals
- -
- -
- -
ST Debt
156
187
118
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
20.68%
10.82%
3.06%
Free Cash Flow
-110.63%
-157.1%
80.34%
Net Income, GAAP
18.02%
47.3%
-42.28%
Sales/Revenue/Turnover
5.44%
7.2%
-3.13%
Total Cash Common Dividend
6,612.92%
13,248.72%
-25.97%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
238
333
324
318
1,214
2025
291
284
- -
320
1,176
2026
296
304
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.12
0.28
0.25
0.15
0.79
2025
0.11
0.12
- -
0.08
0.43
2026
0.11
0.06
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.06
0.17
0.02
0.06
0.29
2025
0.04
0.11
- -
0.03
0.2
2026
0.03
0.11
- -
- -
- -

Company Description

CEO
Hong Tao Liu
Full Time Employees
1,760
Sector
Consumer durables
Industry
Recreational products
Address
Guozhan Fortune Center Qingdao SD China 266200
IPO Date
Sep 15, 2017
Business
Impulse (Qingdao) Health Tech Co.,Ltd. Impulse (Qingdao) Health Tech Co.,Ltd. (002899.SZ) engages in the research, development, manufacture, sales, and branding of fitness equipment under the IMPULSE brand; its principal products include cardio machines such as treadmills, stair climbers, upright bikes, spinning bikes, recumbent bikes, elliptical trainers, indoor cycles, rowers, and air bikes; strength training equipment encompassing plate-loaded and selectorized machines with ergonomic designs for precise power output and muscle targeting; functional training and group training gear; rehabilitation equipment; outdoor fitness apparatus; cage football facilities; and ice/snow training setups, alongside after-sales services. Founded in 2004 with roots tracing back over 40 years from Taiwan operations relocated to Qingdao in 1991, the company is headquartered at No. 369 Huashan No. 2 Road, Jimo City, Qingdao, Shandong Province, China, and employs approximately 1,669 people. It serves diverse customers including health clubs, star hotels, gymnasiums, governments, enterprises, institutions, military and police units, colleges, universities, sports teams, and home users, with sales distributed domestically in China through a network of subsidiaries, offices, distributors, and specialty stores, and internationally to over 70 countries across five continents. Recent developments encompass integration of AI technologies into fitness medical devices for image recognition-based identity authentication and large model compatibility, alongside digital gym systems for scientific fitness in internal testing as of early 2025; orderly advancement of due diligence for an AI glasses project; Q1 2025 revenue growth of 21.91% year-over-year to 291 million yuan; and half-year earnings results reported in August 2025, with approval of a final cash dividend for 2024 payable in June 2025; the company listed on the Shenzhen Stock Exchange in September 2017 as China's first mainboard fitness equipment firm and maintains over 750 patent applications, including 231 granted with 22 inventions.